Please read and agree to the terms and conditions of this site.
@WSJ 3 years ago Breaking: The FDA has delayed a decision on clearing Moderna's Covid-19 vaccine for 12-to-17-year-olds while it looks into the risk of the rare heart condition myocarditis, people familiar with the matter say on.wsj.com